Specialized in the manufacture of sterile products: from production of active ingredients to the manufacture of finished pharmaceutical products.
Recognised as a pharmaceutical site of excellence, a global reference for sterile products for over 50 years, we manufacture for international distribution:
FRAXIPARINE ™ / FRAXODI ™: Low molecular weight heparin indicated for venous thrombo-embolic events
ARIXTRA ™: The only injectable synthetic factor Xa inhibitor indicated both for venous thromboembolic disease and also the treatment of acute coronary syndrome
MONO EMBOLEX™: Low molecular weight heparin indicated for venous thromboembolic events
WFI & DILUENTS TM: Production of 30 millions units VACCINES TM: Transfer projects on progress
In a constantly changing regulatory environment and as a healthcare company, all our employees work with transparency and integrity so that our patients can trust Aspen.
We have mastered all the criteria that guarantee the absence of risks for the patient. Every day, in each of our actions, we think of him, he counts on us.
